Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Mark, E; Kempf, W; Guitart, J; Pulitzer, M; Mitteldorf, C; Hristov, A; Torres-Cabala, C; Marchi, E; Cropley, T; Rodriguez, Pinilla, SM; Griffin, T; Fernandez, R; Pileri, S; Pileri, A; Tabanelli, V; Borretta, L; Subtil, A; Plaza, JA; Piris, JAMA; Feldman, AL; Cerroni, L; Gru, AA.
Lymphomatoid Papulosis With T-cell Receptor-Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis.
Am J Surg Pathol. 2024; Doi: 10.1097/PAS.0000000000002200
Web of Science PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Cerroni Lorenzo
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Lymphomatoid papulosis (LyP) has several histopathologic presentations. LyP featuring gamma-delta (γδ) T-cell receptor expression may masquerade as and may be misdiagnosed as aggressive cutaneous T-cell lymphoma, particularly primary cutaneous γδ T-cell lymphoma (PCGDTL) or γδ mycosis fungoides. We performed a clinicopathologic analysis of the largest series of LyP featuring γδ T-cell expression. We identified 26 patients with a diagnosis of LyP with γδ T cells from our institutions, as well as through a comprehensive review of the literature, and characterized these cases. Most cases were treated with topical steroids or not treated at all. The majority of cases showed a CD4-CD8+ phenotype and featured at least one cytotoxic marker. Histopathologic features included an intraepidermal or dermal infiltrate with large cells and frequent angiotropism. One case was initially misdiagnosed as PCGDTL, requiring further therapy. Our case series, the largest international cohort of γδ T cell predominant LyP cases, confirms marked clinicopathologic heterogeneity that may contribute to misdiagnosis, reasserting the need to identify classic clinical features, CD30+ T-cell components, and markers of cytotoxicity when dealing with this differential diagnosis. A limitation of this study includes somewhat limited follow-up, histologic, and immunophenotypic information for some cases.
Find related publications in this database (Keywords): CD30(+) T-cell lymphoproliferative disorders; cutaneous T-cell lymphoma; dermatopathology; gamma-delta T-cells; immunohistochemistry; lymphomatoid papulosis; mycosis fungoides; primary cutaneous gamma-delta T-cell lymphoma